ELI LILLY & Co (LLY) operating KPIs
LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1417.54+43.84 (+3.19%)
Close on Oct 30, 2026Market cap $1.33TP/E 46.0Yield 0.44%
Eli Lilly other intangible assets, net ($M) ($M)
Form 10-Q / 10-K Consolidated Balance Sheets & Note 7 Goodwill and Intangibles
Latest, FY2025
6,521
Period ended Dec 31, 2025
Change on a year earlier
+5.8%
6,166 in FY2024
History
10 years
Since FY2016
Sources
10
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Other intangible assets, net ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 6,521 | +5.8% | Form 10-Q (filed 2026-08-05) ↗ |
| FY2024 | Dec 31, 2024 | 6,166 | -10.7% | Form 10-K (filed 2026-02-12) ↗ |
| FY2023 | Dec 31, 2023 | 6,907 | -4.2% | Form 10-K (filed 2025-02-19) ↗ |
| FY2022 | Dec 31, 2022 | 7,207 | -6.3% | Form 10-K (filed 2024-02-21) ↗ |
| FY2021 | Dec 31, 2021 | 7,692 | +3.2% | Form 10-K (filed 2023-02-22) ↗ |
| FY2020 | Dec 31, 2020 | 7,450 | +12.6% | Form 10-K (filed 2022-02-23) ↗ |
| FY2019 | Dec 31, 2019 | 6,618 | +519.7% | Form 10-K (filed 2021-02-17) ↗ |
| FY2018 | Dec 31, 2018 | 1,068 | -73.5% | Form 10-K (filed 2020-02-19) ↗ |
| FY2017 | Dec 31, 2017 | 4,029 | -7.5% | Form 10-K (filed 2019-02-19) ↗ |
| FY2016 | Dec 31, 2016 | 4,358 | – | Form 10-K (filed 2018-02-20) ↗ |
Breakdown
What makes up other intangible assets, net ($m)
- Other intangible assets, gross ($M)9,485 · FY2025
- Accumulated intangible amortization ($M)2,963 · FY2025
- Finite-lived marketed products / developed technology, gross ($M)7,916 · FY2025
- Finite-lived marketed products / developed technology, net ($M)4,952 · FY2025
- Indefinite-lived in-process R&D (IPR&D) intangible assets ($M)1,569 · FY2025
- Estimated future intangible amortization — Year 1 ($M)488 · FY2025
- Estimated future intangible amortization — Year 2 ($M)486 · FY2025
- Estimated future intangible amortization — Year 3 ($M)480 · FY2025
- Estimated future intangible amortization — Year 4 ($M)466 · FY2025
- Estimated future intangible amortization — Year 5 ($M)432 · FY2025
Cite this data
StockData. (2026). Eli Lilly Other intangible assets, net ($M) ($M), annual FY2016–FY2025 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/intang_net
See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.